IDPH--Positive preliminary results for pivotal trial of ID

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
IDPH--Positive preliminary results for pivotal trial of ID

An SI Board Since June 1996

Posts	SubjectMarks	Bans	Symbol
1762	27	0	IDPH

Emcee: Roudy	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1612	Webhead, I see you know something of which you speak. Please bear with me. I	A.J. Mullen	-	10/29/1998
1611	Bob, safety and efficacy both I think, but with emphasis on safety on the basis	Maurice Winn	1	10/29/1998
1610	Maurice, isn't the purpose of a phase I trial to determine the maximum safe	Bob L	-	10/29/1998
1609	I don't know what the half life of the cd20 molecule but most cell surface	Webhead	-	10/28/1998
1608	You're right wrt antagonistic. I wasn't using it in the specific biomo	A.J. Mullen	-	10/28/1998
1607	Thank you Webhead. That makes sense, but the non-specific damage you mention	Maurice Winn	1	10/28/1998
1606	As I understand the new treatment protocol (which is spelled out in one of the	Webhead	-	10/28/1998
1605	Hi AJ, thanks for the comments. Both Rituxan and Y2B8 definitely attach to the	Maurice Winn	-	10/28/1998
1604	Maurice, I have no special knowledge, but your comments seem v. logical to me.	A.J. Mullen	-	10/28/1998
1603	IDEC has shown Y2B8 to be a good product though not much information was availa	Maurice Winn	1	10/27/1998
1602	IDEC reported EPS of .08 , .17 higher than Merrill Lynch's forecast of a lo	Douglas Babbin	-	10/21/1998
1601	Yes, the quarterly report reads well and we are on track to better qtrs. Did a	Roudy	-	10/20/1998
1600	IDEC Pharmaceuticals Reports Third Quarter 1998 Results	Rick Costantino	-	10/20/1998
1599	It amazes me that IDEC continues to show strong acceptance of Rituxan, yet here	Roudy	-	10/15/1998
1598	An early indication of very strong Rituxan sales... Genentech Reports Net Inco	Rick Costantino	-	10/15/1998
1597	Hello Maurice. I figured it was about time to wake up Idec shareholders as to o	EZLibra	-	8/8/1998
1596	For McCamant's latest take on the Biotech sector click the following link.	Roudy	-	8/6/1998
1595	The news does not seem to helping	Kushi Kullar	-	8/3/1998
1594	From Briefing.com "Biotech Stocks: specific biotechnology stocks could rec	Platter	-	8/3/1998
1593	Monday's Barron's has some commentary on the prolonged Biotech Bust. Re	Henry Niman	-	8/1/1998
1592	CEO interview at the following address; stock-line.com	Roudy	-	7/28/1998
1591	Preliminary earnings report out: biz.yahoo.com Here is the link to research e	Roudy	-	7/14/1998
1590	Bob, thanks for both posts. Please don't assume I understand anything - al	Maurice Winn	1	7/13/1998
1589	Which part makes you ill? The last sentence? If so, I just felt I should add	Bob L	-	7/13/1998
1588	Bob, "More serious competition might come from IDPH. They have shown good	Maurice Winn	1	7/13/1998

Go to reply# or date (mm/dd/yy):